Together we've now reached 42% funding of the second subproject in the largest lifespan analysis of 601 mTOR modulators. The goal with this project is to uncover the next breakthrough beyond the mTOR inhibitor Rapamycin, which is currently the most promising longevity compound

We’re thrilled to announce that we’ve reached 28% funding for our second subproject, where we’ll screen the remaining 300 mTOR inhibitors! The goal is to uncover the next breakthrough beyond the mTOR inhibitor Rapamycin, which is currently the most promising longevity compound

𝗢𝘂𝗿 𝗗.𝗖. 𝗦𝘂𝗺𝗺𝗶𝘁 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹 𝗕𝗿𝗶𝗲𝗳𝗶𝗻𝗴 𝗶𝘀 𝗻𝗼𝘄 𝗹𝗶𝘃𝗲 𝗼𝗻 𝗬𝗼𝘂𝗧𝘂𝗯𝗲! We were honored to feature opening remarks from Longevity Science Caucus Co-Chairs, Representative @RepGusBilirakis (FL-12) and Representative @RepPaulTonko (NY-20),

My little pet project - op-eds by prominent geroscientists - just got a big boost with a fascinating piece by @fedichev. If you are a renowned expert and want to join the conversation, or if you know one, please DM me. The field needs debate!

In a new op-ed, @fedichev, Director and co-founder of @hacking_aging, argues that truly radical life extension will require both deeper insight into the aging process and more advanced technologies. Read it here:

Yesterday, we at A4LI kicked off our second annual fly-in congressional briefing — and we are proud to have been featured in the latest addition of @Politico Influence! 🧬 Thank you to @RepGusBilirakis, @RepPaulTonko & Dr. Mehmet Oz for helping us kick off a day of 50+ Hill

Buck CEO Eric Verdin joins @mkaeberlein @dogagingproject and Mike Roizin from @ClevelandClinic for a day of congressional lobbying for funding for research on aging. @TheA4LI https://t.co/iX9notvnnH

Clinical Endpoints for Aging Interventions panel by some of the experts in the field! MC: @KarlPfleger Dr. Nir Barzilai (@NirBarzilaiMD) Dr. Kristen Fortney (@bioagelabs) Dr. Matt Kaeberlein (@mkaeberlein/@Optispan_Inc)

@OraBiomedical @mkaeberlein @benblueAK @BittoAlessandro @BKennedy_aging @mitchellblee33 This is such an inspiring initiative! The blend of citizen science, AI, and longevity research is exactly the kind of future-forward approach we need. Count me in—let’s help reshape the future of health, one molecule at a time. @sharafi_eth

Just launched: Defense and Space Applications of Longevity Science Panel. Very important topics we don’t discuss often in the longevity space. Glad we are the ones to introduce it! MC: Jeremy Elser Chris Steele, PhD Bob S. Walker Mitchell Lee, PhD (@OraBiomedical)

Now speaking: George Sutphin (@senmorteco), Assistant Professor at University of Arizona and Chairman of @americanaging. Dr. George Sutphin represents the next generation of rigorous, data-driven aging biology. At the University of Arizona, he leads a lab uncovering the

If intelligence is measured by brain-to-body ratio—the proportion of neurons to total cells—nematodes rank among the smartest animals on Earth. It’s no surprise, then, that unbiased drug screens consistently show mental health medications extending lifespan in these model

https://t.co/X0SoKksHsf

The Alliance for Longevity Initiatives applauds today’s relaunch of the Congressional Caucus for Longevity Science, a bipartisan effort that signals growing momentum for policies that prioritize aging and longevity research. Led by Representatives @RepGusBilirakis (R-FL),

This is great news leading into the @theA4LI summit next week. Huge thank you to the bipartisan group of representatives leading the way on better health for all Americans through support for longevity science. @RepGusBilirakis (R-FL), @RepPaulTonko (D-NY), @DanCrenshawTX

📣 Meet Dr. Mina Peyton, Postdoc at @UABNews, uncovering how estrogen deficiency shapes aging through phosphoproteomics. Catch her talk at #AGEAnnualMeeting2025! 🔗 https://t.co/rixU77uKo6 #HormonalAging #WomensHealthMatters #Phosphoproteomics #Geroscience #LongevityScience

The PEARL trial tested rapamycin's effect on human healthspan and the results are in! Learn more from lead author @SZalzalaMD of @agelessrx_, @OraBiomedical co-founder @mkaeberlein, and @LifespanIO co-founder @KeithComito: https://t.co/oSOTZEqKom By: Josh Conway @LifespanRI

Fellow aging researchers: I'm looking to connect with leading labs working on interventions targeting advanced glycation end products (AGEs). Specifically interested in directed approaches beyond general AGE inhibitors. Who's doing the most innovative work in this space?

@OraBiomedical I watched it and I totally agree that we need more discovery research! And you and the MMC are doing exactly that. Thank you!

reminder: community call friday we're talking roadmap > pump science platform token? > how we gonna sell supplements? > when should we launch the new compounds? > come for the rest time for some brain blasts https://t.co/mSlGww17R6